Metis Global Partners, LLC Abbott Laboratories Transaction History
Metis Global Partners, LLC
- $3.25 Billion
- Q4 2024
A detailed history of Metis Global Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Metis Global Partners, LLC holds 75,066 shares of ABT stock, worth $9.82 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
75,066
Previous 73,577
2.02%
Holding current value
$9.82 Million
Previous $8.39 Million
1.22%
% of portfolio
0.26%
Previous 0.27%
Shares
13 transactions
Others Institutions Holding ABT
# of Institutions
3,377Shares Held
1.33BCall Options Held
10.6MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA169MShares$22.1 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.1 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.89 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.08 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...